Literature DB >> 17024328

Motor cortex inhibitory circuits in dementia with Lewy bodies and in Alzheimer's disease.

R Nardone1, A Bratti, F Tezzon.   

Abstract

To determine whether a peculiar neurophysiological profile may contribute to characterize dementia with Lewy bodies (DLB) vs. Alzheimer disease (AD), we used transcranial magnetic stimulation to examine the excitability of two different inhibitory systems of the motor cortex, short latency intracortical inhibition (SICI) and short latency afferent inhibition (SAI) in 10 patients with DLB, in 13 patients with AD and in 15 healthy subjects. SICI and SAI were significantly reduced in AD patients, while both were not significantly different from the controls in DLB patients. The differential pattern of SICI and SAI exhibited by AD vs. DLB may have diagnostic significance in discriminating DLB from AD. Furthermore, this technique may help to clarify the pathophysiological entity of DLB; since SAI is a cortical phenomenon that depends on central cholinergic activity, our findings suggest that the mechanisms of cholinergic depletion in DLB may be different from that in AD, while normal SICI may reflect a less pronounced dysregulation of the intracortical GABAergic inhibitory circuitries in DLB.

Entities:  

Mesh:

Year:  2006        PMID: 17024328     DOI: 10.1007/s00702-006-0551-1

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  41 in total

1.  Direct demonstration of the effect of lorazepam on the excitability of the human motor cortex.

Authors:  V Di Lazzaro; A Oliviero; M Meglio; B Cioni; G Tamburrini; P Tonali; J C Rothwell
Journal:  Clin Neurophysiol       Date:  2000-05       Impact factor: 3.708

2.  Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease.

Authors:  E K Perry; I McKeith; P Thompson; E Marshall; J Kerwin; S Jabeen; J A Edwardson; P Ince; G Blessed; D Irving
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

3.  Light and electron microscopic study of m2 muscarinic acetylcholine receptor in the basal forebrain of the rat.

Authors:  A I Levey; S M Edmunds; S M Hersch; R G Wiley; C J Heilman
Journal:  J Comp Neurol       Date:  1995-01-16       Impact factor: 3.215

4.  GABA(A) receptor antagonists enhance cortical acetylcholine release induced by 5-HT(3) receptor blockade in freely moving rats.

Authors:  Mónica Diez-Ariza; Mónica García-Alloza; Berta Lasheras; Joaquín Del Río; María Javier Ramírez
Journal:  Brain Res       Date:  2002-11-22       Impact factor: 3.252

5.  The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity.

Authors:  L Hansen; D Salmon; D Galasko; E Masliah; R Katzman; R DeTeresa; L Thal; M M Pay; R Hofstetter; M Klauber
Journal:  Neurology       Date:  1990-01       Impact factor: 9.910

Review 6.  Atypical form of Alzheimer's disease with prominent posterior cortical atrophy: a review of lesion distribution and circuit disconnection in cortical visual pathways.

Authors:  P R Hof; B A Vogt; C Bouras; J H Morrison
Journal:  Vision Res       Date:  1997-12       Impact factor: 1.886

7.  Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease.

Authors:  D D Flynn; G Ferrari-DiLeo; D C Mash; A I Levey
Journal:  J Neurochem       Date:  1995-04       Impact factor: 5.372

8.  Muscarinic and GABAA receptors modulate acetylcholine release in feline basal forebrain.

Authors:  Jacqueline Vazquez; Helen A Baghdoyan
Journal:  Eur J Neurosci       Date:  2003-01       Impact factor: 3.386

9.  Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease.

Authors:  E K Perry; V Haroutunian; K L Davis; R Levy; P Lantos; S Eagger; M Honavar; A Dean; M Griffiths; I G McKeith
Journal:  Neuroreport       Date:  1994-03-21       Impact factor: 1.837

10.  Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study.

Authors:  U Ziemann; S Lönnecker; B J Steinhoff; W Paulus
Journal:  Ann Neurol       Date:  1996-09       Impact factor: 10.422

View more
  16 in total

Review 1.  Noninvasive brain stimulation in Alzheimer's disease: systematic review and perspectives for the future.

Authors:  Catarina Freitas; Helena Mondragón-Llorca; Alvaro Pascual-Leone
Journal:  Exp Gerontol       Date:  2011-04-14       Impact factor: 4.032

2.  Effects of lorazepam and baclofen on short- and long-latency afferent inhibition.

Authors:  Claudia V Turco; Jenin El-Sayes; Mitchell B Locke; Robert Chen; Steven Baker; Aimee J Nelson
Journal:  J Physiol       Date:  2018-10-03       Impact factor: 5.182

Review 3.  Transcranial magnetic stimulation in Alzheimer's disease: a neurophysiological marker of cortical hyperexcitability.

Authors:  Giovanni Pennisi; Raffaele Ferri; Giuseppe Lanza; Mariagiovanna Cantone; Manuela Pennisi; Valentina Puglisi; Giulia Malaguarnera; Rita Bella
Journal:  J Neural Transm (Vienna)       Date:  2011-01-05       Impact factor: 3.575

4.  Dopamine differently modulates central cholinergic circuits in patients with Alzheimer disease and CADASIL.

Authors:  Raffaele Nardone; Yvonne Höller; Aljosha Thomschewski; Alexander Baden Kunz; Piergiorgio Lochner; Stefan Golaszewski; Eugen Trinka; Francesco Brigo
Journal:  J Neural Transm (Vienna)       Date:  2014-03-28       Impact factor: 3.575

5.  Intra- and inter-cortical motor excitability in Alzheimer's disease.

Authors:  Jacqueline Hoeppner; Martin Wegrzyn; Johannes Thome; Alexandra Bauer; Imke Oltmann; Johannes Buchmann; Stefan Teipel
Journal:  J Neural Transm (Vienna)       Date:  2011-11-13       Impact factor: 3.575

Review 6.  Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease.

Authors:  Steve Vucic; Matthew C Kiernan
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

7.  Central cholinergic dysfunction could be associated with oropharyngeal dysphagia in early Parkinson's disease.

Authors:  Kyung Duck Lee; Jung Hoi Koo; Sun Hong Song; Kwang Deog Jo; Moon Kyu Lee; Wooyoung Jang
Journal:  J Neural Transm (Vienna)       Date:  2015-07-22       Impact factor: 3.575

8.  Cholinergic dysfunction in subcortical ischaemic vascular dementia: a transcranial magnetic stimulation study.

Authors:  Raffaele Nardone; Jürgen Bergmann; Frediano Tezzon; Günther Ladurner; Stefan Golaszewski
Journal:  J Neural Transm (Vienna)       Date:  2008-01-11       Impact factor: 3.575

9.  Transcranial magnetic stimulation studies in Alzheimer's disease.

Authors:  Andrea Guerra; Federica Assenza; Federica Bressi; Federica Scrascia; Marco Del Duca; Francesca Ursini; Stefano Vollaro; Laura Trotta; Mario Tombini; Carmelo Chisari; Florinda Ferreri
Journal:  Int J Alzheimers Dis       Date:  2011-07-06

10.  Increased EEG gamma band activity in Alzheimer's disease and mild cognitive impairment.

Authors:  J A van Deursen; E F P M Vuurman; F R J Verhey; V H J M van Kranen-Mastenbroek; W J Riedel
Journal:  J Neural Transm (Vienna)       Date:  2008-07-08       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.